AstraZeneca PLC is a Swedish-British multinational pharmaceutical and biopharmaceutical company with its global headquarters in Cambridge, England. Its R&D is concentrated in Cambridge, Gaithersburg, Maryland, U.S. and Mölndal, Sweden. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014).
A former logistics worker shared this demising review: "The worst part of AstraZeneca is the people. They are absolutely horrible people to be around. Everyone from HR/trainers/supervisors/managers/workers are the worst of the worst. Don't come here. This would however be an ideal place for people with serious felonies who need money for awhile. It would be a good place for someone transitioning out of prison to get back on their feet. Stay away from this company, you will regret taking the job the day you start. The "logistics" operations are 30 years behind anything one could even consider modern. Laziest, trashiest people you will ever come across."